Search

Search Constraints

You searched for: Author/Creator Lerebours, Florence

Search Results

1. Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. Issue 4 (April 2021)

2. Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast Carcinomas. (20th April 2020)

3. Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study. Issue 5 (May 2016)

4. Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer. Issue 19 (1st August 2022)

5. Cognitive change in breast cancer patients up to 2 years after diagnosis. (26th December 2022)

6. Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub‐study of the French CANTO cohort. Issue 4 (31st October 2020)

7. Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis. Issue 19 (1st July 2022)

8. Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status. (April 2017)

9. Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer. (June 2021)

10. MiRNA expression profiling of inflammatory breast cancer identifies a 5‐miRNA signature predictive of breast tumor aggressiveness. Issue 7 (13th April 2013)